Request for Covid-19 Impact Assessment of this Report
The United States Sarcopenia Therapeutic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sarcopenia Therapeutic market, reaching US$ million by the year 2028. As for the Europe Sarcopenia Therapeutic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sarcopenia Therapeutic players cover Abbott Laboratories, Nestlé, Pfizer, and Amway, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sarcopenia Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Protein Supplement
Calcium Supplement
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Online Pharmacies
Retail Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Nestlé
Pfizer
Amway
By-health
Usana
A&Z Pharmaceutical
GlaxoSmithKline
Bayer
H&H
Blackmores
Zhendong Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sarcopenia Therapeutic Market Size 2017-2028
2.1.2 Sarcopenia Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Sarcopenia Therapeutic Segment by Type
2.2.1 Protein Supplement
2.2.2 Calcium Supplement
2.2.3 Other
2.3 Sarcopenia Therapeutic Market Size by Type
2.3.1 Sarcopenia Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Sarcopenia Therapeutic Market Size Market Share by Type (2017-2022)
2.4 Sarcopenia Therapeutic Segment by Application
2.4.1 Online Pharmacies
2.4.2 Retail Pharmacies
2.5 Sarcopenia Therapeutic Market Size by Application
2.5.1 Sarcopenia Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Sarcopenia Therapeutic Market Size Market Share by Application (2017-2022)
3 Sarcopenia Therapeutic Market Size by Player
3.1 Sarcopenia Therapeutic Market Size Market Share by Players
3.1.1 Global Sarcopenia Therapeutic Revenue by Players (2020-2022)
3.1.2 Global Sarcopenia Therapeutic Revenue Market Share by Players (2020-2022)
3.2 Global Sarcopenia Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Sarcopenia Therapeutic by Regions
4.1 Sarcopenia Therapeutic Market Size by Regions (2017-2022)
4.2 Americas Sarcopenia Therapeutic Market Size Growth (2017-2022)
4.3 APAC Sarcopenia Therapeutic Market Size Growth (2017-2022)
4.4 Europe Sarcopenia Therapeutic Market Size Growth (2017-2022)
4.5 Middle East & Africa Sarcopenia Therapeutic Market Size Growth (2017-2022)
5 Americas
5.1 Americas Sarcopenia Therapeutic Market Size by Country (2017-2022)
5.2 Americas Sarcopenia Therapeutic Market Size by Type (2017-2022)
5.3 Americas Sarcopenia Therapeutic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sarcopenia Therapeutic Market Size by Region (2017-2022)
6.2 APAC Sarcopenia Therapeutic Market Size by Type (2017-2022)
6.3 APAC Sarcopenia Therapeutic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Sarcopenia Therapeutic by Country (2017-2022)
7.2 Europe Sarcopenia Therapeutic Market Size by Type (2017-2022)
7.3 Europe Sarcopenia Therapeutic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sarcopenia Therapeutic by Region (2017-2022)
8.2 Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2017-2022)
8.3 Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Sarcopenia Therapeutic Market Forecast
10.1 Global Sarcopenia Therapeutic Forecast by Regions (2023-2028)
10.1.1 Global Sarcopenia Therapeutic Forecast by Regions (2023-2028)
10.1.2 Americas Sarcopenia Therapeutic Forecast
10.1.3 APAC Sarcopenia Therapeutic Forecast
10.1.4 Europe Sarcopenia Therapeutic Forecast
10.1.5 Middle East & Africa Sarcopenia Therapeutic Forecast
10.2 Americas Sarcopenia Therapeutic Forecast by Country (2023-2028)
10.2.1 United States Sarcopenia Therapeutic Market Forecast
10.2.2 Canada Sarcopenia Therapeutic Market Forecast
10.2.3 Mexico Sarcopenia Therapeutic Market Forecast
10.2.4 Brazil Sarcopenia Therapeutic Market Forecast
10.3 APAC Sarcopenia Therapeutic Forecast by Region (2023-2028)
10.3.1 China Sarcopenia Therapeutic Market Forecast
10.3.2 Japan Sarcopenia Therapeutic Market Forecast
10.3.3 Korea Sarcopenia Therapeutic Market Forecast
10.3.4 Southeast Asia Sarcopenia Therapeutic Market Forecast
10.3.5 India Sarcopenia Therapeutic Market Forecast
10.3.6 Australia Sarcopenia Therapeutic Market Forecast
10.4 Europe Sarcopenia Therapeutic Forecast by Country (2023-2028)
10.4.1 Germany Sarcopenia Therapeutic Market Forecast
10.4.2 France Sarcopenia Therapeutic Market Forecast
10.4.3 UK Sarcopenia Therapeutic Market Forecast
10.4.4 Italy Sarcopenia Therapeutic Market Forecast
10.4.5 Russia Sarcopenia Therapeutic Market Forecast
10.5 Middle East & Africa Sarcopenia Therapeutic Forecast by Region (2023-2028)
10.5.1 Egypt Sarcopenia Therapeutic Market Forecast
10.5.2 South Africa Sarcopenia Therapeutic Market Forecast
10.5.3 Israel Sarcopenia Therapeutic Market Forecast
10.5.4 Turkey Sarcopenia Therapeutic Market Forecast
10.5.5 GCC Countries Sarcopenia Therapeutic Market Forecast
10.6 Global Sarcopenia Therapeutic Forecast by Type (2023-2028)
10.7 Global Sarcopenia Therapeutic Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Sarcopenia Therapeutic Product Offered
11.1.3 Abbott Laboratories Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Nestlé
11.2.1 Nestlé Company Information
11.2.2 Nestlé Sarcopenia Therapeutic Product Offered
11.2.3 Nestlé Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Nestlé Main Business Overview
11.2.5 Nestlé Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Sarcopenia Therapeutic Product Offered
11.3.3 Pfizer Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Amway
11.4.1 Amway Company Information
11.4.2 Amway Sarcopenia Therapeutic Product Offered
11.4.3 Amway Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Amway Main Business Overview
11.4.5 Amway Latest Developments
11.5 By-health
11.5.1 By-health Company Information
11.5.2 By-health Sarcopenia Therapeutic Product Offered
11.5.3 By-health Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 By-health Main Business Overview
11.5.5 By-health Latest Developments
11.6 Usana
11.6.1 Usana Company Information
11.6.2 Usana Sarcopenia Therapeutic Product Offered
11.6.3 Usana Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Usana Main Business Overview
11.6.5 Usana Latest Developments
11.7 A&Z Pharmaceutical
11.7.1 A&Z Pharmaceutical Company Information
11.7.2 A&Z Pharmaceutical Sarcopenia Therapeutic Product Offered
11.7.3 A&Z Pharmaceutical Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 A&Z Pharmaceutical Main Business Overview
11.7.5 A&Z Pharmaceutical Latest Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Sarcopenia Therapeutic Product Offered
11.8.3 GlaxoSmithKline Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GlaxoSmithKline Main Business Overview
11.8.5 GlaxoSmithKline Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Sarcopenia Therapeutic Product Offered
11.9.3 Bayer Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 H&H
11.10.1 H&H Company Information
11.10.2 H&H Sarcopenia Therapeutic Product Offered
11.10.3 H&H Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 H&H Main Business Overview
11.10.5 H&H Latest Developments
11.11 Blackmores
11.11.1 Blackmores Company Information
11.11.2 Blackmores Sarcopenia Therapeutic Product Offered
11.11.3 Blackmores Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Blackmores Main Business Overview
11.11.5 Blackmores Latest Developments
11.12 Zhendong Group
11.12.1 Zhendong Group Company Information
11.12.2 Zhendong Group Sarcopenia Therapeutic Product Offered
11.12.3 Zhendong Group Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Zhendong Group Main Business Overview
11.12.5 Zhendong Group Latest Developments
12 Research Findings and Conclusion
Table 1. Sarcopenia Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Protein Supplement
Table 3. Major Players of Calcium Supplement
Table 4. Major Players of Other
Table 5. Sarcopenia Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Sarcopenia Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Sarcopenia Therapeutic Market Size Market Share by Type (2017-2022)
Table 8. Sarcopenia Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Sarcopenia Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Sarcopenia Therapeutic Market Size Market Share by Application (2017-2022)
Table 11. Global Sarcopenia Therapeutic Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Sarcopenia Therapeutic Revenue Market Share by Player (2020-2022)
Table 13. Sarcopenia Therapeutic Key Players Head office and Products Offered
Table 14. Sarcopenia Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Sarcopenia Therapeutic Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Sarcopenia Therapeutic Market Size Market Share by Regions (2017-2022)
Table 19. Americas Sarcopenia Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Sarcopenia Therapeutic Market Size Market Share by Country (2017-2022)
Table 21. Americas Sarcopenia Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Sarcopenia Therapeutic Market Size Market Share by Type (2017-2022)
Table 23. Americas Sarcopenia Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Sarcopenia Therapeutic Market Size Market Share by Application (2017-2022)
Table 25. APAC Sarcopenia Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Sarcopenia Therapeutic Market Size Market Share by Region (2017-2022)
Table 27. APAC Sarcopenia Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Sarcopenia Therapeutic Market Size Market Share by Type (2017-2022)
Table 29. APAC Sarcopenia Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Sarcopenia Therapeutic Market Size Market Share by Application (2017-2022)
Table 31. Europe Sarcopenia Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Sarcopenia Therapeutic Market Size Market Share by Country (2017-2022)
Table 33. Europe Sarcopenia Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Sarcopenia Therapeutic Market Size Market Share by Type (2017-2022)
Table 35. Europe Sarcopenia Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Sarcopenia Therapeutic Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Sarcopenia Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Sarcopenia Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Sarcopenia Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Sarcopenia Therapeutic
Table 44. Key Market Challenges & Risks of Sarcopenia Therapeutic
Table 45. Key Industry Trends of Sarcopenia Therapeutic
Table 46. Global Sarcopenia Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Sarcopenia Therapeutic Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Sarcopenia Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Sarcopenia Therapeutic Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Sarcopenia Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Sarcopenia Therapeutic Market Size Market Share Forecast by Application (2023-2028)
Table 52. Abbott Laboratories Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 53. Abbott Laboratories Sarcopenia Therapeutic Product Offered
Table 54. Abbott Laboratories Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. Nestlé Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 58. Nestlé Sarcopenia Therapeutic Product Offered
Table 59. Nestlé Main Business
Table 60. Nestlé Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Nestlé Latest Developments
Table 62. Pfizer Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 63. Pfizer Sarcopenia Therapeutic Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pfizer Latest Developments
Table 67. Amway Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 68. Amway Sarcopenia Therapeutic Product Offered
Table 69. Amway Main Business
Table 70. Amway Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Amway Latest Developments
Table 72. By-health Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 73. By-health Sarcopenia Therapeutic Product Offered
Table 74. By-health Main Business
Table 75. By-health Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. By-health Latest Developments
Table 77. Usana Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 78. Usana Sarcopenia Therapeutic Product Offered
Table 79. Usana Main Business
Table 80. Usana Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Usana Latest Developments
Table 82. A&Z Pharmaceutical Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 83. A&Z Pharmaceutical Sarcopenia Therapeutic Product Offered
Table 84. A&Z Pharmaceutical Main Business
Table 85. A&Z Pharmaceutical Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. A&Z Pharmaceutical Latest Developments
Table 87. GlaxoSmithKline Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 88. GlaxoSmithKline Sarcopenia Therapeutic Product Offered
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. GlaxoSmithKline Latest Developments
Table 92. Bayer Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 93. Bayer Sarcopenia Therapeutic Product Offered
Table 94. Bayer Main Business
Table 95. Bayer Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Bayer Latest Developments
Table 97. H&H Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 98. H&H Sarcopenia Therapeutic Product Offered
Table 99. H&H Main Business
Table 100. H&H Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. H&H Latest Developments
Table 102. Blackmores Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 103. Blackmores Sarcopenia Therapeutic Product Offered
Table 104. Blackmores Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Blackmores Main Business
Table 106. Blackmores Latest Developments
Table 107. Zhendong Group Details, Company Type, Sarcopenia Therapeutic Area Served and Its Competitors
Table 108. Zhendong Group Sarcopenia Therapeutic Product Offered
Table 109. Zhendong Group Main Business
Table 110. Zhendong Group Sarcopenia Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Zhendong Group Latest Developments
List of Figures
Figure 1. Sarcopenia Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sarcopenia Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Sarcopenia Therapeutic Market Size Market Share by Type in 2021
Figure 7. Sarcopenia Therapeutic in Online Pharmacies
Figure 8. Global Sarcopenia Therapeutic Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 9. Sarcopenia Therapeutic in Retail Pharmacies
Figure 10. Global Sarcopenia Therapeutic Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 11. Global Sarcopenia Therapeutic Market Size Market Share by Application in 2021
Figure 12. Global Sarcopenia Therapeutic Revenue Market Share by Player in 2021
Figure 13. Global Sarcopenia Therapeutic Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Sarcopenia Therapeutic Market Size 2017-2022 ($ Millions)
Figure 15. APAC Sarcopenia Therapeutic Market Size 2017-2022 ($ Millions)
Figure 16. Europe Sarcopenia Therapeutic Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Sarcopenia Therapeutic Market Size 2017-2022 ($ Millions)
Figure 18. Americas Sarcopenia Therapeutic Value Market Share by Country in 2021
Figure 19. Americas Sarcopenia Therapeutic Consumption Market Share by Type in 2021
Figure 20. Americas Sarcopenia Therapeutic Market Size Market Share by Application in 2021
Figure 21. United States Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Sarcopenia Therapeutic Market Size Market Share by Region in 2021
Figure 26. APAC Sarcopenia Therapeutic Market Size Market Share by Application in 2021
Figure 27. China Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Sarcopenia Therapeutic Market Size Market Share by Country in 2021
Figure 34. Europe Sarcopenia Therapeutic Market Size Market Share by Type in 2021
Figure 35. Europe Sarcopenia Therapeutic Market Size Market Share by Application in 2021
Figure 36. Germany Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Sarcopenia Therapeutic Market Size Market Share by Application in 2021
Figure 44. Egypt Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Sarcopenia Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 50. APAC Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 51. Europe Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 53. United States Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 54. Canada Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 57. China Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 58. Japan Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 59. Korea Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 61. India Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 62. Australia Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 63. Germany Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 64. France Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 65. UK Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 66. Italy Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 67. Russia Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 68. Spain Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 71. Israel Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Sarcopenia Therapeutic Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...